Report cover image

Global Biopharmaceutical CMO and CRO Market: Current Analysis and Forecast (2022-2028)

Publisher UnivDatos Market Insights
Published Jan 01, 2023
Length 161 Pages
SKU # Univ17768300

Description

Global Biopharmaceutical CMO and CRO Market: Current Analysis and Forecast (2022-2028)

Biopharmaceutical CMO is the abbreviation used for a biopharmaceutical contract manufacturing organization which is an organization that caters to the biopharmaceutical industry and provides clients services, from drug development to manufacturing. A contract research organization is a service biotechnology industries in the form of outsourced pharmaceutical research services. The rising number of chronic diseases and increasing investments of the major biopharmaceutical industry in the upsurging of production capabilities attributes to the market growth of the biopharmaceutical CMO and CRO market.

The Biopharmaceutical CMO and CRO Market are expected to grow at a steady rate of around 7% owing to the increased participation of major companies and the rising number of CROs and CMOs in the market. For instance, in January 2023, RQM+ launched its clinical trial services division to complete its complement of medtech contract research organization (CRO) services.
  • Based on the source, the market has been bifurcated into mammalian and non-mammalian. Among them, the mammalian segment holds a dominant share of the market in 2020. Mammalian cells are used in the production of recombinant proteins that have a similar structure as that of human cells. Therefore, the use of mammalian cells in recombinant DNA technology and in the production of monoclonal antibodies has increased. This is the factors responsible for the domination of the segment.
  • Based on the services, the market has been bifurcated into contract manufacturing and contract research. Among them, the contract research segment is expected to witness the fastest growth during the forecast period. The rise in the number of clinical trials and the surging demand for gene therapy in the treatment of rare diseases are the important factors driving the growth of the CRO segment in the market. Furthermore, the entrance of new and small-scale players also contributed to the growth of the segment. For example, in 2021, the France-based CRO start-up Zanteris bring customized solutions for the management of clinical trials by using experienced clinical project/clinical operations managers, and flexible & optimal support to the CRO, pharmaceutical, and biotechnology industries.
  • Based on the product, the market has been categorized into biologics and biosimilars. Among them, the biologics category is projected to have a predominant share in the market. The biologics require continuous purification, usually using single-use reactors, and require complex manufacturing steps which encourages the companies to outsource the production of the biologics from CMOS to reduce the operational cost is an important factor for catalyzing the growth of the segment.
  • For a better understanding of the market adoption of the biopharmaceutical CMO and CRO industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated hold a dominant market share in 2020. This is mainly due to the presence of major market players in the region, high research & development investment in biotechnology is responsible for the growth of the market in the region. For instance, in September 2022, The United States announced New Investments and Resources to Advance President Biden’s National Biotechnology and Biomanufacturing Initiative.
  • Some of the major players operating in the market are Boehringer Ingelheim International GmbH, Inc.; Lonza; Rentschler Biopharma SE; JRS PHARMA; ProBioGen AG; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.; TOYOBO CO., LTD.; Samsung Biologics; Thermo Fisher Scientific Inc; and AbbVie Inc.

Table of Contents

161 Pages
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Biopharmaceutical CMO and CRO Market
2.2. Research Methodology of the Biopharmaceutical CMO and CRO Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE BIOPHARMACEUTICAL CMO AND CRO MARKET
6 BIOPHARMACEUTICAL CMO AND CRO MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY SOURCE
7.1. Mammalian
7.2. Non-mammalian
8 MARKET INSIGHTS BY SERVICES
8.1. Contract Manufacturing
8.1.1. Process Development
8.1.2. Fill & Finish Operations
8.1.3. Analytical & QC studies
8.1.4. Packaging
8.2. Contract Research
8.2.1. Oncology
8.2.2. Inflammation & Immunology
8.2.3. Cardiology
8.2.4. Neuroscience
8.2.5. Others
9 MARKET INSIGHTS BY PRODUCT
9.1. Biologics
9.1.1. Monoclonal antibodies (MAbs)
9.1.2. Recombinant Proteins
9.1.3. Vaccines
9.1.4. Antisense, RNAi, & Molecular Therapy
9.1.5. Others
9.2. Biosimilars
10 MARKET INSIGHTS BY REGION
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Rest of North America
10.2. Europe
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest of Asia-Pacific
10.4. Rest of World
11 BIOPHARMACEUTICAL CMO AND CRO MARKET DYNAMICS
11.1. Market Drivers
11.2. Market Challenges
11.3. Impact Analysis
12 BIOPHARMACEUTICAL CMO AND CRO MARKET OPPORTUNITIES
13 BIOPHARMACEUTICAL CMO AND CRO MARKET TRENDS
14 DEMAND AND SUPPLY-SIDE ANALYSIS
14.1. Demand Side Analysis
14.2. Supply Side Analysis
15 VALUE CHAIN ANALYSIS
16 COMPETITIVE SCENARIO
16.1. Competitive Landscape
16.1.1. Porters Fiver Forces Analysis
17 COMPANY PROFILED
17.1. Boehringer Ingelheim International GmbH, Inc
17.2. Lonza
17.3. Rentschler Biopharma SE
17.4. JRS PHARMA
17.5. ProBioGen AG
17.6. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
17.7. TOYOBO CO., LTD.
17.8. Samsung Biologics
17.9. Thermo Fisher Scientific Inc
17.10. AbbVie Inc
18 DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us